<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00810563</url>
  </required_header>
  <id_info>
    <org_study_id>DOPOL 08-294</org_study_id>
    <secondary_id>GPPG 08-293</secondary_id>
    <nct_id>NCT00810563</nct_id>
  </id_info>
  <brief_title>Does Bupivacaine in Laparoscopic Portals Reduce Post Surgery Pain in Tubal Ligation by Electrocoagulation?</brief_title>
  <acronym>DOPOL</acronym>
  <official_title>Assessment of Postoperatory Pain After Laparoscopic Tubal Ligation by Electrocoagulation With Bupivacaine or Placebo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of bupivacaine , an anesthesic, in laparoscopic portals is recommended in some
      surgeries. In the ase of tubal ligation by electrocoagulation, where pain is reduced, there
      is no evidence of this benefit. The objective of this study is to verify the degree of pain
      after laparoscopic tubal ligation surgery in patient who received bupivacaine 0.5% in the
      portal, or placebo
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to conduct this study, the internal and external validation were considered.

      The author will use different gynecological teams, with different expertise to perform the
      laparoscopic tubal ligation, but using the same surgical and anesthesic technique. Second
      year residents, during their rotation, and medical staff will perform the surgery.

      Anesthesic technique:

      Intravenous remifentanil 0.1-0.5 micrograms/kg/min Intravenous Propofol target controlled or
      sevoflurane Intermittent ventilation using O2 40 - 100%, with or without compressed air.
      Before incision: 5mL of bupivacaine 0.5% or saline solution 0.9% from the aponeurosis until
      the skin In the end of the procedure: intravenous 4mg of dexamethasone + 40mg of tenoxican

      Post-operation prescription:

      NPO util well awake, then free according to patient´s tolerance If nausea/vomit:
      metoclopramide 10mg IV If pain: dipyrone 1g IV qid If pain is intense: morphine 3mg IV 3/3 h
      If pain persists: morphine 1mg h/h

      After hospital discharge:

      If pain: sodium diclofenac 50mg tid
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2008</start_date>
  <completion_date type="Anticipated">August 2009</completion_date>
  <primary_completion_date type="Anticipated">March 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>at 15, 30 and 120 minutes and 14 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Use of medication for pain</measure>
    <time_frame>at 15, 30 and 120 minutes after surgery and 14 hours later</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">46</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline solution 0.9% 5mL in each portal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine 0.5% 5mL in each portal</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline solution (laparoscopic tubal ligation)</intervention_name>
    <description>5ml of saline solution in each portal of the trocar (2 portals)</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>5ml of bupivacaine 0.5% in each trocar portal</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients schedule for laparoscopic tubal ligation

        Exclusion Criteria:

          -  Not willing to consent

          -  Use of analgesic within 12 hours prior the surgery

          -  Known allergy or contraindications to bupivacaine, dipyrone, porphine, or sodium
             diclofenac
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo F Savaris, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HCPA/UFRGS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de Clínicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90035-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo F Savaris, MD</last_name>
      <email>rsavaris@hcpa.ufrgs.br</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Rioux JE, Daris M. Female sterilization: an update. Curr Opin Obstet Gynecol. 2001 Aug;13(4):377-81. Review.</citation>
    <PMID>11452199</PMID>
  </reference>
  <reference>
    <citation>Alexander JI. Pain after laparoscopy. Br J Anaesth. 1997 Sep;79(3):369-78. Review.</citation>
    <PMID>9389858</PMID>
  </reference>
  <reference>
    <citation>Colbert ST, Moran K, O'Hanlon DM, Chambers F, Moriarty DC, Blunnie WP. An assessment of the value of intraperitoneal meperidine for analgesia postlaparoscopic tubal ligation. Anesth Analg. 2000 Sep;91(3):667-70.</citation>
    <PMID>10960397</PMID>
  </reference>
  <reference>
    <citation>Curry CS, Darby JR, Janssen BR. Evaluation of pain following electrocautery tubal ligation and effect of intraoperative fentanyl. J Clin Anesth. 1996 May;8(3):216-9.</citation>
    <PMID>8703457</PMID>
  </reference>
  <reference>
    <citation>Chi IC, Cole LP. Incidence of pain among women undergoing laparoscopic sterilization by electrocoagulation, the spring-loaded clip, and the tubal ring. Am J Obstet Gynecol. 1979 Oct 1;135(3):397-401.</citation>
    <PMID>158312</PMID>
  </reference>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2008</study_first_submitted>
  <study_first_submitted_qc>December 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2008</study_first_posted>
  <last_update_submitted>August 27, 2009</last_update_submitted>
  <last_update_submitted_qc>August 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 28, 2009</last_update_posted>
  <responsible_party>
    <name_title>Ricardo Francalacci Savaris</name_title>
    <organization>HCPA - UFRGS</organization>
  </responsible_party>
  <keyword>pain</keyword>
  <keyword>tubal ligation</keyword>
  <keyword>bupivacaine</keyword>
  <keyword>laparoscopy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>June 4, 2010</submitted>
    <returned>July 6, 2010</returned>
    <submitted>July 7, 2010</submitted>
    <returned>August 4, 2010</returned>
    <submitted>February 15, 2011</submitted>
    <returned>March 10, 2011</returned>
    <submitted>April 20, 2011</submitted>
    <returned>May 12, 2011</returned>
    <submitted>September 4, 2012</submitted>
    <returned>October 3, 2012</returned>
    <submitted>August 19, 2015</submitted>
    <returned>September 21, 2015</returned>
    <submitted>June 28, 2017</submitted>
    <returned>January 26, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

